No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C

Journal of Affective Disorders

Volumn 129, Issue 1-3, 2011, Pages 205-212

  Kronfol, Ziad ^a   Litman, Heather J ^b   Back Madruga, Carla ^c   Bieliauskas, Linas A ^d,e   Lindsay, Karen L ^c   Lok, Anna S ^f   Fontana, Robert J ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Beck Depression Inventory; Cytokines; Interferon; Mood states; Neuropsychiatric toxicity

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROCORTISONE; PEGINTERFERON ALPHA2A; RIBAVIRIN; SEROTONIN;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SEROTONIN BLOOD LEVEL;

ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HEPATITIS C; HUMANS; HYDROCORTISONE; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; TIME FACTORS;

EID: 79851511608     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.09.010     Document Type: Article

References (45)

1. N.H. Afdhal, R. Levine, R. Brown Jr., B. Freilich, M. O'Brien, and C. Brass Colchicine versus peg-interferon alfa 2B long term therapy: results of the 4 year copilot trial J. Hepatol. 48 Supp 2 2008 abstract #3
2. A.T. Beck, R.A. Steer, and G.K. Brown BDI-II Manual 1996 Harcourt Brace and Company San Antonio, TX
3. W. Cai, V.I. Khaoustov, Q. Xie, T. Pan, W. Le, and B. Yoffe Interferon-α-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression J. Hepatol. 42 2005 880 887
4. L. Capuron, and A. Ravaud Prediction of the depressive effects of interferon alfa therapy by the patients initial affective state [letter] N Engl J. Med. 340 1999 1370
5. L. Capuron, G. Neurauter, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, D. Fuchs, and A.H. Miller Interferon-alpha-induced changes in tryptophan metabolism relationship to depression and paroxetine treatment Biol. Psychiatry 54 2003 906 914 (Pubitemid 37311353)
6. L. Capuron, C.L. Raison, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, and A.H. Miller Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am. J. Psychiatry 10 2003 1342 1345 (Pubitemid 41070955)
7. J. Cordoba, M. Flavia, C. Jacas, S. Sauleda, J.I. Esteban, V. Vargas, R. Esteban, and J. Guardia Quality of life and cognitive function in hepatitis C at different stages of liver disease J. Hepatol. 39 2003 231 238 (Pubitemid 36920559)
8. E.P.M. Corsmit, R. Heijligenberg, E. Endert, M.T. Ackermans, H.P. Sauerwein, and J.A. Romijin Endocrine and metabolic effects of interferon-α in humans J. Clin. Endocrinol. Metab. 81 1996 3265 3269 (Pubitemid 26296200)
9. A.M. Di Bisceglie, M.L. Shiffman, G.T. Everson, K.L. Lindsay, J.E. Everhart, E.C. Wright, W.M. Lee, A.S. Lok, H.L. Bonkovsky, T.R. Morgan, M.G. Ghany, C. Morishima, K.K. Snow, J.L. Dienstag, and H.A.L.T.-C. Trial Investigators Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon N Engl J. Med. 359 2008 2429 2441
10. E. Dieperink, M. Willenbring, and S.B. Ho Neuropsychiatric symptoms associated with hepatitis C and interferon α: a review Am. J. Psychiatry 157 2000 867 876 (Pubitemid 30412335)
11. E. Dieperink, S.B. Ho, P. Thuras, and M.L. Willenbring A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C Psychosomatics 44 2003 104 112 (Pubitemid 36241123)
12. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lactot A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2009 446 457
13. A.J. Dunn, and J. Wang Cytokine effects on CNS biogenic amines Neuroimmunomodulation 2 1995 319 328 (Pubitemid 26233179)
14. A.M. Eggermont, S. Suciu, M. Santinami, A. Testori, W.H. Kruit, J. Marsden, C.J. Punt, F. Salès, M. Gore, R. Mackie, Z. Kusic, R. Dummer, A. Hauschild, E. Musat, A. Spatz, U. Keilholz, and E.O.R.T.C. Melanoma Group Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage IIII melanoma: final results of EORTC 18991, a randomized phase III trial Lancet 372 2008 117
15. D.M. Evon, D. Ramcharran, S.H. Belle, N.A. Terrault, R.J. Fontana, M.W. Fried the ViraHep-C Study Group Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the ViraHep-C study Am. J. Gastroenterol. 104 2009 2949 2958
16. A. Farah Interferon-induced depression treated with citalopram J. Clin. Psychiatry 63 2002 166 167
17. L. Fartoux, F. Degos, C. Trepo, O. Goria, P. Cales, A. Tran, C. Buffet, T. Poynard, D. Capron, J.J. Raabe, D. Roulot, S. Naveau, J.D. Grange, R.E. Pupon, and L. Serfaty Effect of prolonged interferon therapy on the outcome of hepatitis C virus related cirrhosis: a randomized trial Clin. Gasteroenterol. Hepatol. 5 2007 502 507 (Pubitemid 46575357)
18. R.J. Fontana, L.A. Bieliauskas, C. Back-Madruga, K.L. Lindsay, Z. Kronfol, A.S.F. Lok, L. Padmanabhan, and for the HALT-C Trial Group Cognitive function in Hepatitis C patients with advanced fibrosis in the HALT-C Trial J. Hepatology 43 2005 614 622 (Pubitemid 41253228)
19. R.J. Fontana, Z. Kronfol, K.L. Lindsay, L.A. Bieliauskas, L. Padmanabhan, C. Back-Madruga, A.S.F. Lok, A.M. Stoddard, and H.A.L.T.-C. Trial Group Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C Am. J. Gastroenterol. 103 2008 2766 2775
20. R.J. Fontana, L. Bieliauskas, C. Back-Madruga, K.L. Lindsay, H.J. Litman, A.S.F. Lok, Z. Kronfol HALT-C Trial Group Cognitive function does not worsen during long-term low dose peginterferon therapy in patients with chronic hepatitis C Am. J. Gastroenterol. 105 2010 1551 1560
21. M.W. Fried, and M.A. Russo Side effects of antiviral therapy for hepatitis C Gastroenterology 124 2003 1711 1719 (Pubitemid 36617688)
22. O.C. Gleason, W.R. Yates, M.D. Isbell, and M.A. Philipsen An open label trial of citalopram for major depression in patients with hepatitis C J. Clin. Psychiatry 63 2002 194 198 (Pubitemid 34407077)
23. P. Hauser, J. Kholsa, H. Aurora, J. Laurin, M.A. Kling, J. Hill, M. Gulati, A.J. Thornton, R.L. Schultz, A.D. Valentine, C.A. Meyers, and C.D. Howell A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C Mol. Psychiatry 9 2002 942 947 (Pubitemid 35333048)
24. R.C. Hilsabeck, T.I. Hassanein, M.D. Carlson, E.A. Zielger, and W. Perry Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C J. Int. Neuropsychol. Soc. 9 2003 847 854 (Pubitemid 37139014)
25. Z. Kronfol, and D.G. Remick Cytokines and the brain: implications for clinical psychiatry Am. J. Psychiatry 157 2000 683 694 (Pubitemid 30249643)
26. W.M. Lee, J.L. Dienstag, A.S. Lok, H.L. Bonkovsky, M.L. Shiffman, G.T. Everson, A.M. Di Bisceglie, T.R. Morgan, M.G. Ghany, C. Morishima, E.C. Wright, J.E. Everhart HALT-C Trial Group Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders Control. Clin. Trials 25 2004 472 492 (Pubitemid 39299157)
27. S.S. Lee, V.G. Bain, K. Peltekian, M. Krajden, E.M. Yoshida, M. Deschenes, J. Heathcote, R.J. Bailey, S. Simonyi, and M. Sherman Treating chronic hepatitis C with pegylated interferon alfa-2a (40 kD) and ribavirin in clinical practice Aliment. Pharmacol. Ther. 23 2006 397 408 (Pubitemid 43382020)
28. F.X. Mahon, X. Delbrei, P. Cony-Makhoul, C. Fabères, J.M. Boiron, C. Barthe, C. Bilhou-Nabéra, A. Pigneux, G. Marit, and J. Reiffers Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa-1 Clin. Oncol. 20 2002 214
29. M. Malaguarnera, I. Di Fazio, S. Restuccia, G. Pistone, L. Ferlito, and L. Rampello Interferon alpha induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha Neuropsychobiology 37 1998 93 97 (Pubitemid 28143024)
30. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol Psychiatry 65 2009 732 741
31. L.A. Mistler, M.F. Brunette, B.J. Marsh, R.M. Vidaver, R. Luckoor, and S.D. Rosenberg Hepatitis C treatment for people with severe mental illness Psychosomatics 47 2006 93 107 (Pubitemid 43346956)
32. D.L. Musselman, D.H. Lawson, J.F. Gumnick, A.K. Manatunga, S. Penna, R.S. Goodkin, K. Greiner, C.B. Nemeroff, and A.H. Miller Paroxetine for the prevention of depression induced by high-dose interferon alfa N Engl J. Med. 344 2001 961 966 (Pubitemid 32240314)
33. R. Pugh, I. Murray-Lyon, J. Dawson, M. Pietroni, and R. Williams Transection of the esophagus for bleeding esophageal varices Br. J. Surg. 60 1973 646 649
34. C.L. Raison, M. Demetrashvili, L. Capuron, and A.H. Miller Neuropsychiatric adverse effects of interferon-α: recognition and management CNS Drugs 19 2005 105 123 (Pubitemid 40321763)
35. R. Sapolsky, C. Rivier, G. Yamamoto, P. Plotsky, and W.W. Vale Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor Science 238 1987 522 524 (Pubitemid 17147036)
36. M. Schaefer, M.A. Engelbrecht, O. Gut, B.L. Fiebich, J. Bauer, F. Schmidt, H. Grunz, and K. Lieb Interferon alpha (IFNalpha) and psychiatric syndromes: a review Prog. Neuropsychoparmacol. Biol. Psychiatry 26 2002 731 746 (Pubitemid 34615979)
37. M. Schaefer, M. Schwaiger, and T. Berg Citalopram for the prevention of interferon-α associated depression in psychiatric risk patients Hepatology 38 4 Suppl. 1 2003 320A
38. A. Schäfer, M. Scheurlen, J. Seufert, C. Keicher, B. Weissbrich, P. Reiger, and M. Kraus Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression J. Hepatol. 52 2010 10 15
39. M.L. Shiffman, A.M. Di Bisceglie, K.L. Lindsay, C. Morishima, E.C. Wright, G.T. Everson, A.S. Lok, T.R. Morgan, H.L. Bonkovsky, W.M. Lee, J.L. Dienstag, M.G. Ghany, Z.D. Goodman, J.E. Everhart Hepatitis C antiviral long-term treatment against cirrhosis Trial Group Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment Gasteroenterology 126 2004 1015 1023 (Pubitemid 38451173)
40. L.J. Siever, and K.L. Davis Overview: toward a dysregulation hypothesis of depression Am. J. Psychiatry 142 1985 1017 1031 (Pubitemid 16250774)
41. H.A. Skinner, and W.J. Sheu Reliability of alcohol use indices: the lifetime drinking history and the MAST J. Stud. Alcohol 43 1982 1157 1170 (Pubitemid 13082703)
42. K.K. Snow, H.L. Bonkovsky, R.J. Fontana, H.Y. Kim, R.K. Sterling, A.M. Di Bisceglie, T.R. Morgan, J.L. Dienstag, M.G. Ghany the HALT-C Trial Group Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C Aliment. Pharm. Ther. 31 2010 719 734
43. M.C. Wichers, G.H. Koek, G. Robaeys, R. Verkerk, S. Scharpe, and M. Maes IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol. Psychiatry 10 2005 538 544 (Pubitemid 40897037)
44. H.U. Wittchen Reliability and validity studies of the WHO Composite International Diagnostic Interview: a critical review J. Psychiatr. Res. 28 1994 57 84
45. E.P. Zorrilla, L. Luborsky, J.R. McKay, R. Roesenthal, A. Houldin, A. Tax, R. McCorkle, D.A. Seligman, and K. Schmidt The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav. Immun. 15 2001 199 226 (Pubitemid 33070955)